IN158324B - - Google Patents

Info

Publication number
IN158324B
IN158324B IN180/CAL/84A IN180CA1984A IN158324B IN 158324 B IN158324 B IN 158324B IN 180CA1984 A IN180CA1984 A IN 180CA1984A IN 158324 B IN158324 B IN 158324B
Authority
IN
India
Prior art keywords
derivative
crosslinked fibrin
fibrin derivative
extract
steps
Prior art date
Application number
IN180/CAL/84A
Other languages
English (en)
Inventor
Peter Gregory Bundesen
Dennis Brian Rylatt
Original Assignee
Fielder Gillespie Davis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3770042&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN158324(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fielder Gillespie Davis Ltd filed Critical Fielder Gillespie Davis Ltd
Publication of IN158324B publication Critical patent/IN158324B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745Assays involving non-enzymic blood coagulation factors
    • G01N2333/75Fibrin; Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN180/CAL/84A 1983-03-17 1984-03-13 IN158324B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPF849483 1983-03-17

Publications (1)

Publication Number Publication Date
IN158324B true IN158324B (es) 1986-10-18

Family

ID=3770042

Family Applications (1)

Application Number Title Priority Date Filing Date
IN180/CAL/84A IN158324B (es) 1983-03-17 1984-03-13

Country Status (18)

Country Link
US (1) US4758524A (es)
EP (1) EP0122478B2 (es)
JP (1) JPS59183696A (es)
KR (1) KR840008288A (es)
AT (1) ATE99738T1 (es)
AU (1) AU572125B2 (es)
CA (1) CA1247022A (es)
DE (1) DE3486262T3 (es)
DK (1) DK158284A (es)
ES (1) ES530691A0 (es)
GR (1) GR81951B (es)
IL (1) IL71264A (es)
IN (1) IN158324B (es)
NO (1) NO167338C (es)
NZ (1) NZ207459A (es)
PH (1) PH22957A (es)
PT (1) PT78267B (es)
ZA (1) ZA841878B (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722903A (en) * 1983-11-14 1988-02-02 New York Blood Center, Inc. Monoclonal antibodies specific to in vivo fragments derived from human fibrinogen, human fiberin I or human fibrin II
DE3400434A1 (de) * 1984-01-09 1985-09-26 Behringwerke Ag, 3550 Marburg Bestimmung von fibrin mit fibrin-spezifischen antikoerpern
JPS60166698A (ja) * 1984-02-09 1985-08-29 Dai Ichi Pure Chem Co Ltd モノクロ−ナル抗体
US4927916A (en) * 1984-04-23 1990-05-22 The General Hospital Corporation Method of producing fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity using fibrin-specific peptides
US5357042A (en) * 1984-04-23 1994-10-18 The General Hospital Corporation Synthetic peptides capable of eliciting fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity
FR2569276B1 (fr) * 1984-08-14 1988-02-05 Stago Diagnostica Procede de dosage de produits de degradation du fibrinogene
US5116613A (en) * 1985-01-08 1992-05-26 The General Hospital Corporation Antibody-thrombolytic agent product and method of use
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
FR2593518B1 (fr) * 1985-05-02 1989-09-08 Transgene Sa Vecteurs d'expression et de secretion de l'hirudine par les levures transformees
US4916070A (en) * 1986-04-14 1990-04-10 The General Hospital Corporation Fibrin-specific antibodies and method of screening for the antibodies
JPH0746104B2 (ja) * 1986-09-22 1995-05-17 株式会社ヤトロン Fdpの測定法
US5102787A (en) * 1987-07-10 1992-04-07 Miho Sasamata Method, device and kit for measurement of tissue plasminogen activator activity
US5582862A (en) 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
US5372812A (en) * 1988-04-04 1994-12-13 The General Hospital Corporation Composition and method for acceleration of clot lysis
US5453359A (en) * 1988-06-13 1995-09-26 American Biogenetic Sciences, Inc. Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers
US5120834A (en) * 1988-06-13 1992-06-09 American Biogenetic Sciences, Inc. Fibrin-specific monoclonal antibody
IE67430B1 (en) * 1988-06-24 1996-04-03 Res Corp Technologies Inc Assay for soluble crosslinked fibrin polymers
US5206140A (en) * 1988-06-24 1993-04-27 Research Corporation Technologies, Inc. Assay for soluble crosslinked fibrin polymers
US5609869A (en) * 1988-08-19 1997-03-11 The General Hospital Corporation Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use
US5811265A (en) * 1988-08-19 1998-09-22 The General Hospital Corporation Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use
CA2023354C (en) * 1989-08-17 2002-08-13 Karen Ann Thomas Method for direct chemical binding of d-dimer from a biological sample for diagnosing and monitoring thrombolytic and hypercoagulable states
WO1991002547A1 (en) * 1989-08-24 1991-03-07 Australian Nuclear Science & Technology Organisation Radio-labelled antibodies for imaging
FR2663748B1 (fr) * 1990-06-22 1992-10-09 Oris Ind Cie Anticorps specifiques de la liaison isopeptidique induite par les transglutaminases, antigenes constitues par des isopeptides glu-lys reconnus par lesdits anticorps, agents de diagnostic et compositions therapeutiques les contenant.
US5550160A (en) * 1992-07-31 1996-08-27 Australian Nuclear Science & Technology Organization Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents
US5807535A (en) * 1992-07-31 1998-09-15 Australian Nuclear Science & Technology Organisation Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents
US5487892A (en) * 1994-02-24 1996-01-30 American Biogenetic Sciences, Inc. Method for treating thrombotic disease using a fibrin specific monoclonal antibody
JP2001502895A (ja) * 1996-09-20 2001-03-06 ザ・ジェネラル・ホスピタル・コーポレイション アルファ―2―抗プラスミンに対するキメラ、ヒト化および一本鎖抗体
US20020106708A1 (en) * 2000-11-13 2002-08-08 Sigma-Aldrich Co. Assays reagents and kits for detecting or determining the concentration of analytes
US20030003515A1 (en) * 2000-12-05 2003-01-02 Farrell David H. Monocloral antibody-based diagnostic assay for gamma fibrinogen
CA2450828C (en) * 2001-06-26 2013-11-26 Agen Biomedical Limited Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin
US20030219853A1 (en) * 2002-03-01 2003-11-27 Szu-Yi Chou Method of cross-linking a compound
US7485438B2 (en) * 2002-03-01 2009-02-03 Szu-Yi Chou Method of producing polyvalent antigens
US20040001848A1 (en) * 2002-03-01 2004-01-01 Szu-Yi Chou Method of producing disease-specific antigens
US20030224476A1 (en) * 2002-03-01 2003-12-04 Szu-Yi Chou Method of producing transglutaminase reactive compound
DE102004052082A1 (de) 2004-10-26 2006-04-27 Dade Behring Marburg Gmbh Durchstoßbare, flexible Vorrichtung zur Abdeckung von Flüssigkeitsbehältnissen
US11506674B2 (en) 2005-07-29 2022-11-22 Princeton Biomeditech Corporation Monoclonal antibody against D-dimer and diagnosis agent for detecting D-dimer, crosslinked fibrin and its derivatives containing D-dimer by using the antibody
US8940489B2 (en) * 2005-07-29 2015-01-27 Hyun-Ju Doh Monoclonal antibody against D-dimer and diagnosis agent for detecting D-dimer, crosslinked fibrin and its derivatives containing D-dimer by using the antibody
US9206250B2 (en) 2010-04-01 2015-12-08 Lsi Medience Corporation Monoclonal antibodies and method of immunological analysis of D-dimer
WO2012014996A1 (ja) * 2010-07-30 2012-02-02 シスメックス株式会社 Fdp測定用試薬及び試薬キット、並びに測定方法
TWI658268B (zh) * 2017-11-29 2019-05-01 國立清華大學 血液檢測方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
AU2373384A (en) * 1982-12-06 1984-06-14 Fielder Gillespie Davis Ltd. Field immunoassay reaction system
JPS59155762A (ja) * 1982-12-06 1984-09-04 フイ−ルダ−・ジルレスピ−・デイビス・リミテツド フイ−ルドイムノアツセイ反応システムおよび方法
US4722903A (en) * 1983-11-14 1988-02-02 New York Blood Center, Inc. Monoclonal antibodies specific to in vivo fragments derived from human fibrinogen, human fiberin I or human fibrin II

Also Published As

Publication number Publication date
PH22957A (en) 1989-02-03
EP0122478A3 (en) 1987-04-01
EP0122478B1 (en) 1994-01-05
IL71264A (en) 1987-10-20
JPH0583240B2 (es) 1993-11-25
NO841023L (no) 1984-09-18
NO167338B (no) 1991-07-15
DK158284D0 (da) 1984-03-16
PT78267B (en) 1986-04-21
ZA841878B (en) 1984-10-31
PT78267A (en) 1984-04-01
AU572125B2 (en) 1988-05-05
KR840008288A (ko) 1984-12-14
US4758524A (en) 1988-07-19
CA1247022A (en) 1988-12-20
NO167338C (no) 1993-12-15
ATE99738T1 (de) 1994-01-15
GR81951B (es) 1984-12-12
DE3486262D1 (de) 1994-02-17
DE3486262T2 (de) 1994-06-16
EP0122478A2 (en) 1984-10-24
IL71264A0 (en) 1984-06-29
DE3486262T3 (de) 2000-10-26
ES8507694A1 (es) 1985-09-01
DK158284A (da) 1984-09-18
NZ207459A (en) 1987-11-27
AU2538784A (en) 1984-09-20
EP0122478B2 (en) 2000-04-12
ES530691A0 (es) 1985-09-01
JPS59183696A (ja) 1984-10-18

Similar Documents

Publication Publication Date Title
GR81951B (es)
AU3615384A (en) Method of detecting immiune complexes in serium
NO166465C (no) Fremgangsmaate for bestemmelse av sekvensen av monomerer.
US4379839A (en) Method for detecting cancer
EP0248534A3 (en) Method of detecting aids virus infection
AU1245188A (en) Analyte detection in particulate-containing samples
DE3667061D1 (en) New protein isolated from blood, process for preparing said protein, antibodies against said new protein, and pharmaceutical compositions containing said protein or said antibodies
CA2062820A1 (en) Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates
DE68911574T2 (de) Reagenzsystem zur Bestimmung des Komplexes des menschlichen Plasminogenaktivator-Inhibitors und des menschlichen Gewebeplasminogenaktivators und Testsatz dafür.
CA1287801C (en) Method for determining human collagen peptides by way of enzyme immunoassay
CA2264275C (en) Monoclonal antibody specific to an anti-human fibrin monomer, method for producing the monoclonal antibody, hybridoma, and immunoassay
JPS55152458A (en) Method of eliminating immunoreaction interference in immunological measurement method
NO165128C (no) Fremgangsmaate for eliminering av falske positive resultater fra systemiske lupuserythematodes-pasienter ved bestemmelse av et atl-virusantistoff i en testproeve.
EP0248147A3 (en) Method of determining the presence of cancer cells
AU7059187A (en) Method for the detection of pregnancy disorders
Veale et al. Quantitation of autoantibodies to cytokeratins in sera from patients with squamous cell carcinoma of the oesophagus
Nishimura et al. Appearance of abnormal catalase antigen and concurrent deletion of normal antigen in leukocytes of myelogenous leukemia
US4442088A (en) Tumor enzyme detection
JPS5646465A (en) Measuring method for man pancreas secretory inhibiter in humor
JPS6488368A (en) Method for measuring complex of urokinase and urokinase inhibitor
AU573748B2 (en) Monoclonal antibody to cancer procoagulant and immunoassay
GB1514639A (en) Test method to determine pulmonary embolism
JPS5633555A (en) Immunilogical measuring method for substance forming combined body
JPS5616414A (en) Preparation of antigen
ES8608049A1 (es) Juego de ensayo para efectuar la determinacion inmunologica de la forma o formas enzimaticas de las nucleosido-nucleoti-do-fosfotransferasas